Additional individual analysis of the expression pattern of key oncogenic TFs verified this clear trend of elevated expression among the transcriptomes of the MYCN-amplified compared to the non-MYCN-amplified neuroblastoma cell lines (Figure 2, center and right, dot plots). The gene discussed is MYCN; the disease is neuroblastoma.